Shen, K.-Y.; Liu, H.-Y.; Yan, W.-L.; Wu, C.-C.; Lee, M.-H.; Leng, C.-H.; Liu, S.-J.
Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells. Cancers 2020, 12, 810.
https://doi.org/10.3390/cancers12040810
AMA Style
Shen K-Y, Liu H-Y, Yan W-L, Wu C-C, Lee M-H, Leng C-H, Liu S-J.
Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells. Cancers. 2020; 12(4):810.
https://doi.org/10.3390/cancers12040810
Chicago/Turabian Style
Shen, Kuan-Yin, Hsin-Yu Liu, Wan-Lun Yan, Chiao-Chieh Wu, Ming-Hui Lee, Chih-Hsing Leng, and Shih-Jen Liu.
2020. "Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells" Cancers 12, no. 4: 810.
https://doi.org/10.3390/cancers12040810
APA Style
Shen, K.-Y., Liu, H.-Y., Yan, W.-L., Wu, C.-C., Lee, M.-H., Leng, C.-H., & Liu, S.-J.
(2020). Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells. Cancers, 12(4), 810.
https://doi.org/10.3390/cancers12040810